UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neurotrophic Factors in Cannabis-induced Psychosis: An Update

Current topics in medicinal chemistry, 2024-01, Vol.24 (20), p.1757-1772

2024

Volltextzugriff (PDF)

Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review

Healthcare (Basel), 2024-01, Vol.12 (3), p.339

2024

Volltextzugriff (PDF)

Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study

Pharmaceuticals (Basel, Switzerland), 2024-04, Vol.17 (4), p.535

2024

Volltextzugriff (PDF)

Aberrant salience in cannabis-induced psychosis: a comparative study

Frontiers in psychiatry, 2024-01, Vol.14, p.1343884-1343884

2024

Volltextzugriff (PDF)

GABAA receptor subtype specific enhancement of inhibition in human motor cortex

The Journal of physiology, 2006-09, Vol.575 (3), p.721-726

2006

Volltextzugriff (PDF)

Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation

Journal of clinical medicine, 2024-04, Vol.13 (8), p.2206

2024

Volltextzugriff (PDF)

Lurasidone in first-episode psychosis with predominant depressive symptoms: a case report

International clinical psychopharmacology, 2023-07, Vol.38 (4), p.275-280

2023

Volltextzugriff (PDF)

The Loss of Spatiality and Temporality in Twilight Consciousness: The Emergence of Exogenous Psychosis Induced by Novel Psychoactive Substances

Psychopathology, 2024, Vol.57 (3), p.248-258

2024

Volltextzugriff (PDF)

Dissociation and Temporality in Substance Abuse: A Clinical Phenomenological Overview

Psychopathology, 2024, Vol.57 (3), p.219-228

2024

Volltextzugriff (PDF)

The Resurgence of Exogenous Psychosis: A Phenomenological Examination of Substance-Induced Psychopathology

The journal of nervous and mental disease, 2024-09, Vol.212 (9), p.457-459

2024

Volltextzugriff (PDF)

Comparative analysis of third-generation antipsychotics in first-episode schizophrenia: efficacy, safety, and cognitive impacts. A narrative review

International clinical psychopharmacology, 2024-06

2024

Volltextzugriff (PDF)

Heautoscopic hallucinations in first episode psychosis: report of one case and clinical overview

Psychosis, 2024-07, Vol.16 (3), p.284-291

2024

Volltextzugriff (PDF)

Remission of persistent methamphetamine-induced psychosis after cariprazine therapy: presentation of a case report

Journal of addictive diseases, 2022, Vol.40 (1), p.145-148

2022

Volltextzugriff (PDF)

Internet Gaming Disorders and Early Onset Psychosis in Young People: A Case Study and Clinical Observations

International journal of environmental research and public health, 2023-02, Vol.20 (5), p.3920

2023

Volltextzugriff (PDF)

First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness

Psychiatry research, 2023-02, Vol.320, p.115053

2023

Volltextzugriff (PDF)

CLINICAL STUDY: BRIEF REPORT: Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms

Addiction biology, 2010-07, Vol.15 (3), p.365-367

2010

Volltextzugriff (PDF)

Can it be Helpful to Assess Uric Acid Levels in Daily Psychiatric Clinical Practice?

ALPHA PSYCHIATRY, 2023-03, Vol.24 (2), p.49-50

2023

Volltextzugriff (PDF)

First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation

Psychiatry research, 2023-02, Vol.320, p.115053, Article 115053

2023

Volltextzugriff (PDF)

Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms

The international journal of neuropsychopharmacology, 2016-05, Vol.19 (5), p.pyw003

2016

Volltextzugriff (PDF)

Efficacy and suitability of adding short-term psychodynamic psychotherapy (STPP) to pharmacotherapy in patients with depressive disorders: a systematic review

Trends in psychiatry and psychotherapy, 2024-04

2024

Volltextzugriff (PDF)

Effects of seasonality in emergency admissions for mental disorders: two years of clinical experience

International journal of psychiatry in clinical practice, 2024-03, Vol.28 (1), p.45-52

2024

Volltextzugriff (PDF)

GABA A receptor subtype specific enhancement of inhibition in human motor cortex

The Journal of physiology, 2006-09, Vol.575 (3), p.721-726

2006

Volltextzugriff (PDF)

Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms

International journal of environmental research and public health, 2021-11, Vol.18 (23), p.12632

2021

Volltextzugriff (PDF)

Chronic ketamine use increases serum levels of brain-derived neurotrophic factor

Psychopharmacologia, 2011-05, Vol.215 (1), p.143-148

2011

Volltextzugriff (PDF)

CANNABIS USE AND SUICIDE IN NON-AFFECTIVE PSYCHOSIS: A MINI-REVIEW OF RECENT LITERATURE

Psychiatria Danubina, 2023, Vol.35 (3), p.307-319

2023

Volltextzugriff (PDF)

1 – 25 von 278

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(241)
Mit Volltextzugriff
(211)

Publikationsform

Sprache

Englisch
(252)
Italienisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Neurotrophic Factors in Cannabis-induced Psychosis: An Update

Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review

Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study

Aberrant salience in cannabis-induced psychosis: a comparative study

GABAA receptor subtype specific enhancement of inhibition in human motor cortex

Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation

Lurasidone in first-episode psychosis with predominant depressive symptoms: a case report

The Loss of Spatiality and Temporality in Twilight Consciousness: The Emergence of Exogenous Psychosis Induced by Novel Psychoactive Substances

Dissociation and Temporality in Substance Abuse: A Clinical Phenomenological Overview

The Resurgence of Exogenous Psychosis: A Phenomenological Examination of Substance-Induced Psychopathology

Comparative analysis of third-generation antipsychotics in first-episode schizophrenia: efficacy, safety, and cognitive impacts. A narrative review

Heautoscopic hallucinations in first episode psychosis: report of one case and clinical overview

Remission of persistent methamphetamine-induced psychosis after cariprazine therapy: presentation of a case report

Internet Gaming Disorders and Early Onset Psychosis in Young People: A Case Study and Clinical Observations

First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness

CLINICAL STUDY: BRIEF REPORT: Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms

Can it be Helpful to Assess Uric Acid Levels in Daily Psychiatric Clinical Practice?

First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation

Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms

Efficacy and suitability of adding short-term psychodynamic psychotherapy (STPP) to pharmacotherapy in patients with depressive disorders: a systematic review

Effects of seasonality in emergency admissions for mental disorders: two years of clinical experience

GABA A receptor subtype specific enhancement of inhibition in human motor cortex

Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms

Chronic ketamine use increases serum levels of brain-derived neurotrophic factor

CANNABIS USE AND SUICIDE IN NON-AFFECTIVE PSYCHOSIS: A MINI-REVIEW OF RECENT LITERATURE

Suchergebnisse filtern